Stemnovate Limited
Research and experimental development on biotechnology · Cambridge
ActiveUnited KingdomIncorporated 2016Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-09-30
IXBRL · 51 source facts · 18 selected values
Validation findingsXBRL valid
Accounts to 2025-09-30
IXBRL · 51 source facts · 18 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-10-01 to 2025-09-30
- Extraction status
- complete
- Numeric facts
- 22
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2603_10140603_20250930
- Source archive
- Accounts_Monthly_Data-March2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-09-30
IXBRL · 51 source facts · 18 selected values
Validation findingsXBRL valid
Accounts to 2024-09-30
IXBRL · 51 source facts · 18 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-10-01 to 2024-09-30
- Extraction status
- complete
- Numeric facts
- 22
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2504_10140603_20240930
- Source archive
- Accounts_Monthly_Data-April2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-09-30
IXBRL · 50 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2023-09-30
IXBRL · 50 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2022-10-01 to 2023-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 22
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_10140603_20230930
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2022-09-30
IXBRL · 50 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2022-09-30
IXBRL · 50 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2021-10-01 to 2022-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 22
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0018_10140603_20220930
- Source archive
- Accounts_Monthly_Data-June2023.zip
Accounts to 2021-09-30
IXBRL · 51 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2021-09-30
IXBRL · 51 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2020-10-01 to 2021-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 22
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0106_10140603_20210930
- Source archive
- Accounts_Monthly_Data-May2022.zip
Accounts to 2020-09-30
IXBRL · 62 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2020-09-30
IXBRL · 62 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2019-10-01 to 2020-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 21
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0085_10140603_20200930
- Source archive
- Accounts_Monthly_Data-December2020.zip
Accounts to 2019-09-30
IXBRL · 76 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2019-09-30
IXBRL · 76 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2018-10-01 to 2019-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 32
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0073_10140603_20190930
- Source archive
- Accounts_Monthly_Data-December2019.zip
Registered details
10140603- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2016-04-22
- Jurisdiction
- —
- Registered office
- MAIA BUILDING (270), BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsExploring the role of non-canonical autophagy in human iPSC models of neurodegenerationActiveBBSRC · Studentship · 2028-09-29 – 2028-09-29 · with 1 other participant£0whole project
Exploring the role of non-canonical autophagy in human iPSC models of neurodegenerationActive
BBSRC · Studentship · 2028-09-29 – 2028-09-29 · with 1 other participant
£0
whole project
University Of CambridgeleadStemnovate Ltd
Non-Newtonian Slippery Liquid Infused Porous Surfaces: NN-SLIPSEPSRC · Research Grant · 2020-03-31 – 2024-03-31 · with 2 other participants£347,346whole project
Non-Newtonian Slippery Liquid Infused Porous Surfaces: NN-SLIPS
EPSRC · Research Grant · 2020-03-31 – 2024-03-31 · with 2 other participants
£347,346
whole project
Northumbria UniversityleadSheffield Hallam UniversityStemnovate Ltd
Exploiting stem cell and gene editing technologies towards discovery of genetic variants important for muscle development and meat productionBBSRC · Studentship · 2019-09-07 – 2024-03-31 · with 1 other participant£0whole project
Exploiting stem cell and gene editing technologies towards discovery of genetic variants important for muscle development and meat production
BBSRC · Studentship · 2019-09-07 – 2024-03-31 · with 1 other participant
£0
whole project
University Of EdinburghleadStemnovate Ltd
Modelling foetal liver development and disruption using pluripotent stem cellsMRC · Studentship · 2018-08-31 – 2022-02-28 · with 1 other participant£0whole project
Modelling foetal liver development and disruption using pluripotent stem cells
MRC · Studentship · 2018-08-31 – 2022-02-28 · with 1 other participant
£0
whole project
University Of EdinburghleadStemnovate Ltd
'Liver on a chip' an advanced microfluidic in vitro model for liver toxicity & safety screening.LeadInnovate UK · Collaborative R&D · 2017-10-01 – 2019-12-31 · with 1 other participant£745,508awarded
'Liver on a chip' an advanced microfluidic in vitro model for liver toxicity & safety screening.Lead
Innovate UK · Collaborative R&D · 2017-10-01 – 2019-12-31 · with 1 other participant
£745,508
awarded
Stemnovate Limitedlead£745,508
The development of 3-dimensional implantable liver organoidsMRC · Research Grant · 2014-09-30 – 2018-04-09 · with 6 other participants£1,626,381whole project
The development of 3-dimensional implantable liver organoids
MRC · Research Grant · 2014-09-30 – 2018-04-09 · with 6 other participants
£1,626,381
whole project
University Of EdinburghleadBiolaminaBrunel University LondonChinese Academy of SciencesLeibniz AssociationStemnovate LimitedUniversity of North Carolina at Chapel Hill
A hub for Engineering and exploiting the stem cell nicheMRC · Research Grant · 2013-11-01 – 2018-03-30 · with 17 other participants£4,690,073whole project
A hub for Engineering and exploiting the stem cell niche
MRC · Research Grant · 2013-11-01 – 2018-03-30 · with 17 other participants
£4,690,073
whole project
University Of EdinburghleadAstellas PharmaAstrazenecaBio-Techne LtdGlaxoSmithKline (GSK)Janssen Research & DevelopmentKarolinska InstituteKeele UniversityMateriomicsMiltenyi Biotec GmBHNational Phenotypic Screening CentreNovartis Institutes for BioMedical Research (NIBR)Perkin ElmerSanofiStemnovate LimitedUniversity of StrathclydeWellcome Sanger InstituteXintela AB